HBV Alliance: Program Overview
This program is designed to meet the educational needs of community-based healthcare providers at Federally Qualified Health Centers (FQHCs) and community health centers who are involved in the diagnosis and management of patients
The HBV Alliance will focus on advancing HBV management and therapeutics knowledge by establishing a platform and forum for health care professionals to experience high-quality education delivered by leading experts in the field.
Upon completion of this activity, participants should be able to:
Review data on the prevalence and transmission of HBV
Define the risk of HBV among different patient populations, highlighting high-risk settings
Describe the detrimental effects of untreated, chronic HBV to emphasize the need for diagnosis and treatment
Demonstrate strategies to incorporate various diagnostic and treatment guidelines into clinical practice
Analyze approved and emerging treatment options for HBV
Identify patients that are likely to benefit from emerging treatment options versus currently available therapies
The ECHO model™ breaks down the walls between specialty and primary care. It links expert specialist teams at an academic ‘hub’ with primary care clinicians in local communities — the ‘spokes’ of the model. Essentially, ECHO® creates ongoing learning communities where primary care clinicians receive support and develop the skills they need to treat a particular condition. As a result, they can provide comprehensive, best-practice care to patients with complex health conditions, right where they live.
This program is supported by an educational grant from Gilead Sciences.